IN2014CN03683A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN03683A IN2014CN03683A IN3683CHN2014A IN2014CN03683A IN 2014CN03683 A IN2014CN03683 A IN 2014CN03683A IN 3683CHN2014 A IN3683CHN2014 A IN 3683CHN2014A IN 2014CN03683 A IN2014CN03683 A IN 2014CN03683A
- Authority
- IN
- India
- Prior art keywords
- biological valve
- artificial biological
- pretreated
- glutaraldehyde
- groups
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2415—Manufacturing methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0029—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Manufacturing & Machinery (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110339534.3A CN102499993B (zh) | 2011-11-01 | 2011-11-01 | 一种边缘刚性化人工生物瓣膜的制备方法 |
PCT/CN2011/083987 WO2013063842A1 (fr) | 2011-11-01 | 2011-12-14 | Procédé pour la préparation de valvule biologique artificielle rigidifiée sur les bords |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN03683A true IN2014CN03683A (fr) | 2015-09-04 |
Family
ID=46212166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3683CHN2014 IN2014CN03683A (fr) | 2011-11-01 | 2011-12-14 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2774630B1 (fr) |
CN (1) | CN102499993B (fr) |
AU (1) | AU2011380375B2 (fr) |
BR (1) | BR112014010668B1 (fr) |
ES (1) | ES2639424T3 (fr) |
IN (1) | IN2014CN03683A (fr) |
WO (1) | WO2013063842A1 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
US10433952B2 (en) | 2016-01-29 | 2019-10-08 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
CN109996581B (zh) | 2016-11-21 | 2021-10-15 | 内奥瓦斯克迪亚拉公司 | 用于快速收回经导管心脏瓣膜递送系统的方法和系统 |
CN107007887B (zh) * | 2017-02-27 | 2020-10-02 | 杭州启明医疗器械股份有限公司 | 一种交联人工生物瓣膜及其制备方法 |
WO2019036810A1 (fr) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Prothèse de valvule mitrale transcathéter à déploiement séquentiel |
WO2019092736A1 (fr) * | 2017-11-13 | 2019-05-16 | Meril Life Sciences Pvt Ltd | Anti-calcification d'un tissu |
CA3132873A1 (fr) | 2019-03-08 | 2020-09-17 | Neovasc Tiara Inc. | Systeme de pose de prothese recuperable |
JP7438236B2 (ja) | 2019-04-01 | 2024-02-26 | ニオバスク ティアラ インコーポレイテッド | 制御可能に展開可能な補綴弁 |
CN113924065A (zh) | 2019-04-10 | 2022-01-11 | 内奥瓦斯克迪亚拉公司 | 具有自然血流的假体瓣膜 |
EP3972673A4 (fr) | 2019-05-20 | 2023-06-07 | Neovasc Tiara Inc. | Dispositif d'introduction avec mécanisme d'hémostase |
CA3143344A1 (fr) | 2019-06-20 | 2020-12-24 | Neovasc Tiara Inc. | Valve mitrale prothetique a profil bas |
WO2021118964A1 (fr) * | 2019-12-09 | 2021-06-17 | Edwards Lifesciences Corporation | Préparation de tissu bioprothétique |
CN111467574B (zh) * | 2020-04-21 | 2021-01-26 | 四川大学 | 基于edc/nhs活化和重组人源胶原蛋白修饰的生物瓣膜材料及其制备方法 |
CN115998955A (zh) * | 2022-12-09 | 2023-04-25 | 首都医科大学附属北京安贞医院 | 一种静脉桥的醛铬复合交联方法 |
CN117563049B (zh) * | 2024-01-15 | 2024-05-03 | 北京佰仁医疗科技股份有限公司 | 用于后巩膜加固的眼科生物补片及其制备 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2523810B1 (fr) * | 1982-03-23 | 1988-11-25 | Carpentier Alain | Tissu biologique greffable et procede pour sa preparation |
EP0804255B1 (fr) * | 1994-07-29 | 2001-10-04 | Edwards Lifesciences Corporation | Procedes de traitement des tissus biologiques implantables visant a reduire leur calcification |
WO1997032615A1 (fr) * | 1996-03-04 | 1997-09-12 | Baxter International Inc. | Composes epoxy non polymeres destines a la reticulation de tissus biologiques et greffons pour bioprotheses ainsi obtenus |
WO1997046266A1 (fr) * | 1996-06-03 | 1997-12-11 | Gore Enterprise Holdings, Inc. | Perfectionnement de surfaces de contact avec le sang comportant une matrice extracellulaire synthetisee in vitro et sur laquelle sont immobilisees des especes bioactives |
US6214054B1 (en) * | 1998-09-21 | 2001-04-10 | Edwards Lifesciences Corporation | Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby |
JP2003509168A (ja) * | 1999-09-22 | 2003-03-11 | バクスター・インターナショナル・インコーポレイテッド | 心臓弁および生物学的組織作製方法 |
US20040153145A1 (en) * | 2002-11-26 | 2004-08-05 | Clemson University | Fixation method for bioprostheses |
US7579381B2 (en) * | 2005-03-25 | 2009-08-25 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
US20060217804A1 (en) * | 2005-03-25 | 2006-09-28 | Dove Jeffrey S | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
CN101161293A (zh) * | 2006-10-12 | 2008-04-16 | 胡盛寿 | 异种生物组织材料的抗钙化改性方法 |
CN102114269B (zh) * | 2011-02-22 | 2013-12-11 | 上海微创医疗器械(集团)有限公司 | 一种异氰基封端型防钙化人工生物瓣及其制备方法 |
-
2011
- 2011-11-01 CN CN201110339534.3A patent/CN102499993B/zh active Active
- 2011-12-14 BR BR112014010668-1A patent/BR112014010668B1/pt active IP Right Grant
- 2011-12-14 AU AU2011380375A patent/AU2011380375B2/en active Active
- 2011-12-14 ES ES11875085.0T patent/ES2639424T3/es active Active
- 2011-12-14 WO PCT/CN2011/083987 patent/WO2013063842A1/fr active Application Filing
- 2011-12-14 IN IN3683CHN2014 patent/IN2014CN03683A/en unknown
- 2011-12-14 EP EP11875085.0A patent/EP2774630B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
WO2013063842A1 (fr) | 2013-05-10 |
EP2774630B1 (fr) | 2017-07-05 |
AU2011380375B2 (en) | 2015-09-17 |
ES2639424T3 (es) | 2017-10-26 |
EP2774630A4 (fr) | 2015-07-22 |
BR112014010668A2 (pt) | 2017-12-05 |
AU2011380375A1 (en) | 2014-05-29 |
EP2774630A1 (fr) | 2014-09-10 |
BR112014010668B1 (pt) | 2019-04-02 |
CN102499993B (zh) | 2014-01-15 |
CN102499993A (zh) | 2012-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014CN03683A (fr) | ||
TW201129419A (en) | Method for improving rejection of permeable membrane and permeable membrane | |
MX349658B (es) | Metodo para la diferenciacion de las celulas madre pluripotentes en celulas de lecho vascular. | |
GB2485725A (en) | Systems and methods for optimizing enterprise performance | |
WO2011022369A3 (fr) | Procédé de traitement de tissus | |
MX342200B (es) | Método de tratamiento de células madre mesenquimales y su uso en el tratamiento de enfermedades asociadas a estrés oxidativo. | |
AR060902A1 (es) | Conservadores de bebidas | |
MY178152A (en) | Isolation of stem cells from adipose tissue by ultrasonic cavitation, and methods of use | |
WO2010091049A3 (fr) | Diagnostic et traitement du cancer | |
EA201300780A1 (ru) | Способ получения индуцированных плюрипотентных стволовых клеток и дифференцированных клеток | |
WO2010088064A3 (fr) | Conservation de l'ergothionéine | |
AR077403A1 (es) | Un metodo para la produccion de una bebida alcoholica con un contenido de alcohol reducido | |
MX2013000026A (es) | Proceso de estabilizacion y teñido para fresas. | |
GB2497453A (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
MX2016006656A (es) | Metodos para tratar rechazo mediado por anticuerpos en pacientes de trasplante de organos con inhibidor de c1-esterasa. | |
MX2013006838A (es) | Composiciones efervescentes y uso de las mismas. | |
BRPI1009574A2 (pt) | Método para reduzir a produção de co2 em um processo de fermentação para produzir um álcool, e, microorganismo modificado. | |
MX2013007053A (es) | Uso de compuestos que libera peroxigeno libre de nitrogeno para reducir el crecimiento de microorganismos contaminates en la fermentacion de etanol. | |
WO2012116077A3 (fr) | Procédés d'amélioration de l'aspect d'une peau vieillissante à l'aide d'une composition comprenant des fractions de sérum de banyan, de lotus et de trèfle | |
WO2012116055A3 (fr) | Procédés pour l'amélioration de l'aspect d'une peau hyperpigmentée à l'aide d'une composition synergique comprenant des fractions sériques de banian, de lotus et de trèfle | |
CA2810119C (fr) | Inhibiteurs de clec14a | |
ATE521249T1 (de) | Verfahren zur herstellung fermentierter getränke | |
MX2014013049A (es) | Composiciones y metodos para sulfato de heparan como un biomarcador para rechazo de trasplante. | |
WO2011129607A3 (fr) | Procédé pour augmenter l'activité de cellules souches et cellules souches produites par celui-ci | |
UA47189U (ru) | Способ повышения производительности и улучшения мясных качеств гусей в условиях загрязнения окружающей среды радионуклидами |